Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

A multinational, multi-institutional study comparing positive surgical margin rates among 22393 open, laparoscopic, and robot-assisted radical prostatectomy patients.

Autor: Sooriakumaran P; Surgical Intervention Trials Unit, Nuffield Department of Surgical Sciences, University of Oxford, Oxford, UK; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden. Electronic address: sooriakumaran@gmail.com., Srivastava A; Department of Urology, Montefiore Medical Center, New York, NY, USA., Shariat SF; Department of Urology, Weill Cornell Medical College-New York Presbyterian Hospital, New York, NY, USA; Department of Urology, Medical University of Vienna, Vienna, Austria., Stricker PD; Prostate Cancer Centre, St. Vincent's Clinic, Sydney, Australia., Ahlering T; Department of Urology, University of California-Irvine School of Medicine, Irvine, CA, USA., Eden CG; Department of Urology, Royal Surrey County Hospital, Guildford, UK., Wiklund PN; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden., Sanchez-Salas R; Department of Urology, L'Institut Mutualiste Montsouris, Paris, France., Mottrie A; Department of Urology, Onze-Lieve-Vrouwziekenhuis Hospital, Aalst, Belgium., Lee D; Department of Urology, University of Pennsylvania, Philadelphia, PA, USA., Neal DE; Department of Uro-oncology, University of Cambridge, Cambridge, UK; Uro-oncology Research Group, Cancer Research UK, Cambridge Research Institute, Cambridge, UK., Ghavamian R; Department of Urology, Montefiore Medical Center, New York, NY, USA., Nyirady P; Department of Urology, Semmelweis University, Budapest, Hungary., Nilsson A; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden., Carlsson S; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden., Xylinas E; Department of Urology, Weill Cornell Medical College-New York Presbyterian Hospital, New York, NY, USA., Loidl W; Department of Urology, St. Vincent's Hospital, Linz, Austria., Seitz C; Department of Urology, Medical University of Vienna, Vienna, Austria., Schramek P; Department of Urology, Saint John of God Hospital, Vienna, Austria., Roehrborn C; Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX, USA., Cathelineau X; Department of Urology, L'Institut Mutualiste Montsouris, Paris, France., Skarecky D; Department of Urology, University of California-Irvine School of Medicine, Irvine, CA, USA., Shaw G; Uro-oncology Research Group, Cancer Research UK, Cambridge Research Institute, Cambridge, UK., Warren A; Department of Histopathology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK., Delprado WJ; Prostate Cancer Centre, St. Vincent's Clinic, Sydney, Australia., Haynes AM; Prostate Cancer Centre, St. Vincent's Clinic, Sydney, Australia., Steyerberg E; Department of Public Health, Erasmus MC-University Medical Center Rotterdam, Rotterdam, The Netherlands., Roobol MJ; Department of Public Health, Erasmus MC-University Medical Center Rotterdam, Rotterdam, The Netherlands., Tewari AK; Department of Urology, Weill Cornell Medical College-New York Presbyterian Hospital, New York, NY, USA.

Publikováno v: European urology [Eur Urol] 2014 Sep; Vol. 66 (3), pp. 450-6. Date of Electronic Publication: 2013 Nov 24.

CD44 variant 6 is associated with prostate cancer metastasis and chemo-/radioresistance.

Autor: Ni J; Cancer Care Centre and Prostate Cancer Institute, St George Hospital, Kogarah, Australia; St George and Sutherland Clinical School, University of New South Wales (UNSW), Kensington, Australia., Cozzi PJ, Hao JL, Beretov J, Chang L, Duan W, Shigdar S, Delprado WJ, Graham PH, Bucci J, Kearsley JH, Li Y

Publikováno v: The Prostate [Prostate] 2014 May; Vol. 74 (6), pp. 602-17. Date of Electronic Publication: 2014 Feb 12.

Co-expression of CD147 (EMMPRIN), CD44v3-10, MDR1 and monocarboxylate transporters is associated with prostate cancer drug resistance and progression.

Autor: Hao J; Faculty of Medicine, UNSW, Kensington NSW 2052, Australia., Chen H, Madigan MC, Cozzi PJ, Beretov J, Xiao W, Delprado WJ, Russell PJ, Li Y

Publikováno v: British journal of cancer [Br J Cancer] 2010 Sep 28; Vol. 103 (7), pp. 1008-18. Date of Electronic Publication: 2010 Aug 24.

The fetal adrenal gland: definitive cortex cystic change, lipid patterns, and their relationship to fetal disease and maturity.

Autor: Delprado WJ, Baird PJ

Publikováno v: Pathology [Pathology] 1984 Jul; Vol. 16 (3), pp. 312-7.